VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $69,541,000 | +29.5% | 2,992,282 | -11.3% | 0.30% | +37.6% |
| Q1 2018 | $53,682,000 | -24.4% | 3,372,013 | -1.3% | 0.22% | -31.2% |
| Q4 2017 | $70,987,000 | +33.7% | 3,416,124 | -7.8% | 0.32% | +26.4% |
| Q3 2017 | $53,108,000 | -17.9% | 3,706,065 | -0.9% | 0.25% | -7.6% |
| Q2 2017 | $64,726,000 | +60.4% | 3,741,413 | +2.3% | 0.28% | +113.2% |
| Q1 2017 | $40,346,000 | -24.3% | 3,657,821 | -0.3% | 0.13% | -34.8% |
| Q4 2016 | $53,267,000 | -43.6% | 3,668,511 | -4.6% | 0.20% | -48.4% |
| Q3 2016 | $94,401,000 | +26.8% | 3,845,266 | +4.0% | 0.38% | +17.1% |
| Q2 2016 | $74,455,000 | -30.5% | 3,696,882 | -9.2% | 0.33% | -34.0% |
| Q1 2016 | $107,098,000 | -74.9% | 4,072,178 | -3.0% | 0.50% | -77.0% |
| Q4 2015 | $426,707,000 | -43.8% | 4,197,809 | -1.4% | 2.16% | -42.5% |
| Q3 2015 | $759,431,000 | -21.1% | 4,257,377 | -1.7% | 3.76% | -9.8% |
| Q2 2015 | $962,548,000 | +7.4% | 4,332,876 | -4.0% | 4.17% | +13.9% |
| Q1 2015 | $896,189,000 | +42.5% | 4,512,077 | +2.7% | 3.66% | +55.1% |
| Q4 2014 | $628,870,000 | +3.8% | 4,394,312 | -4.8% | 2.36% | +8.8% |
| Q3 2014 | $605,617,000 | +10.0% | 4,615,981 | +5.7% | 2.17% | +13.4% |
| Q2 2014 | $550,679,000 | -5.4% | 4,366,307 | -1.2% | 1.92% | -13.9% |
| Q1 2014 | $582,342,000 | +11.8% | 4,417,373 | -0.4% | 2.22% | +3.1% |
| Q4 2013 | $520,730,000 | +12.7% | 4,435,523 | +0.2% | 2.16% | +12.9% |
| Q3 2013 | $462,049,000 | +25.1% | 4,428,729 | +3.2% | 1.91% | +15.4% |
| Q2 2013 | $369,282,000 | – | 4,289,986 | – | 1.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |